Alvotech ALVO

NAS: ALVO | ISIN: LU2458332611 15/09/2026

5,020 USD (-0,59%)

(-0,59%) 15/09/2026

Grafiek Alvotech

Grafiek Alvotech

1 dag1d -0,59%
1 week1w -4,20%
1 maand1m 29,38%
3 maanden3m 28,22%
6 maanden6m 31,41%
1 jaar1j -36,70%
5 jaar5j -55,14%

Alvotech in het nieuws

Toon enkel gratis nieuws

31 augustus 2026 · Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations · Persbericht

27 augustus 2026 · Alvotech to present at upcoming investor conferences in September · Persbericht

21 augustus 2026 · Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets · Persbericht

19 augustus 2026 · Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update · Persbericht

10 augustus 2026 · Alvotech to Report Financial Results for H1 2026 · Persbericht

29 juli 2026 · Alvotech announces successful closure of FDA inspection of manufacturing facility · Persbericht

3 juli 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

1 juli 2026 · Alvotech further strengthens liquidity by securing term loan facility of $75 million · Persbericht

23 juni 2026 · Transactions of Managers and Closely Associated Persons · Persbericht

18 juni 2026 · Alvotech Announces Closing of Public Offering and Full Exercise by Underwriters of Option to Purchase Additional Shares, Raising an Aggregate of $165 Million with Concurrent Private Placement · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe